{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T21:15:07Z","timestamp":1757452507720,"version":"3.40.3"},"publisher-location":"Berlin, Heidelberg","reference-count":141,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642221439"},{"type":"electronic","value":"9783642221446"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-22144-6_48","type":"book-chapter","created":{"date-parts":[[2013,6,14]],"date-time":"2013-06-14T07:54:30Z","timestamp":1371196470000},"page":"1439-1467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiangiogenic Alkaloids from Plants"],"prefix":"10.1007","author":[{"given":"Fl\u00e1via Cristine Mascia","family":"Lopes","sequence":"first","affiliation":[]},{"given":"Luis Oct\u00e1vio","family":"Regasini","sequence":"additional","affiliation":[]},{"given":"Manuel Nuno","family":"de Magalh\u00e3es Pinheiro Al\u00e7ada","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Soares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,5,15]]},"reference":[{"issue":"21","key":"48_CR00481","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285(21):1182\u20131186. doi:10.1056\/NEJM197111182852108","journal-title":"N Engl J Med"},{"issue":"4\u20135","key":"48_CR00482","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1387\/ijdb.103211dr","volume":"55","author":"D Ribatti","year":"2011","unstructured":"Ribatti D, Djonov V (2011) Angiogenesis in development and cancer today. Int J Dev Biol 55(4\u20135):343\u2013344. doi:103211dr [pii] or 10.1387\/ijdb.103211dr","journal-title":"Int J Dev Biol"},{"issue":"2","key":"48_CR00483","first-page":"237","volume":"52","author":"AW Griffioen","year":"2000","unstructured":"Griffioen AW, Molema G (2000) Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev 52(2):237\u2013268","journal-title":"Pharmacol Rev"},{"issue":"3","key":"48_CR00484","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4","volume":"261","author":"RJ Tomanek","year":"2000","unstructured":"Tomanek RJ, Schatteman GC (2000) Angiogenesis: new insights and therapeutic potential. Anat Rec 261(3):126\u2013135. doi:10.1002\/1097-0185(20000615)261:3<126::AID-AR7>3.0.CO;2-4 [pii]","journal-title":"Anat Rec"},{"issue":"1","key":"48_CR00485","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1096\/fj.01-0300rev","volume":"16","author":"F Tosetti","year":"2002","unstructured":"Tosetti F, Ferrari N, De Flora S, Albini A (2002) Angioprevention\u2019: angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16(1):2\u201314. doi:10.1096\/fj.01-0300rev or 16\/1\/2 [pii]","journal-title":"FASEB J"},{"issue":"6801","key":"48_CR00486","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249\u2013257. doi:10.1038\/35025220","journal-title":"Nature"},{"issue":"3","key":"48_CR00487","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","volume":"10","author":"C Costa","year":"2007","unstructured":"Costa C, Incio J, Soares R (2007) Angiogenesis and chronic inflammation: cause or consequence? Angiogenesis 10(3):149\u2013166. doi:10.1007\/s10456-007-9074-0","journal-title":"Angiogenesis"},{"issue":"12","key":"48_CR00488","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.intimp.2004.07.017","volume":"4","author":"XW Bian","year":"2004","unstructured":"Bian XW, Chen JH, Jiang XF, Bai JS, Wang QL, Zhang X (2004) Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol 4(12):1537\u20131547. doi:10.1016\/j.intimp. 2004.07.017 or S1567-5769(04)00231-0 [pii]","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"48_CR00489","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0006-2952(00)00529-3","volume":"61","author":"S Liekens","year":"2001","unstructured":"Liekens S, De Clercq E, Neyts J (2001) Angiogenesis: regulators and clinical applications. Biochem Pharmacol 61(3):253\u2013270. doi:S0006-2952(00)00529-3 [pii]","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"48_CR004810","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ptr.3224","volume":"25","author":"SJ Jeong","year":"2011","unstructured":"Jeong SJ, Koh W, Lee EO, Lee HJ, Bae H, Lu J, Kim SH (2011) Antiangiogenic phytochemicals and medicinal herbs. Phytother Res 25(1):1\u201310. doi:10.1002\/ptr.3224","journal-title":"Phytother Res"},{"issue":"1","key":"48_CR004811","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1568010053622830","volume":"4","author":"A Naldini","year":"2005","unstructured":"Naldini A, Carraro F (2005) Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4(1):3\u20138","journal-title":"Curr Drug Targets Inflamm Allergy"},{"issue":"2","key":"48_CR004812","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nm0206-171","volume":"12","author":"BA Imhof","year":"2006","unstructured":"Imhof BA, Aurrand-Lions M (2006) Angiogenesis and inflammation face off. Nat Med 12(2):171\u2013172. doi:nm0206-171 [pii] or 10.1038\/nm0206-171","journal-title":"Nat Med"},{"issue":"1","key":"48_CR004813","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/jcp.10479","volume":"200","author":"SA Paul","year":"2004","unstructured":"Paul SA, Simons JW, Mabjeesh NJ (2004) HIF at the crossroads between ischemia and carcinogenesis. J Cell Physiol 200(1):20\u201330. doi:10.1002\/jcp. 10479","journal-title":"J Cell Physiol"},{"key":"48_CR004814","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/82_2010_74","volume":"345","author":"HZ Imtiyaz","year":"2010","unstructured":"Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105\u2013120. doi:10.1007\/82_2010_74","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"48_CR004815","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1):27\u201331","journal-title":"Nat Med"},{"issue":"3","key":"48_CR004816","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353\u2013364. doi:S0092-8674(00)80108-7 [pii]","journal-title":"Cell"},{"issue":"5","key":"48_CR004817","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/8379","volume":"5","author":"P Carmeliet","year":"1999","unstructured":"Carmeliet P, Ng YS, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, Ehler E, Kakkar VV, Stalmans I, Mattot V, Perriard JC, Dewerchin M, Flameng W, Nagy A, Lupu F, Moons L, Collen D, D'Amore PA, Shima DT (1999) Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 5(5):495\u2013502. doi:10.1038\/8379","journal-title":"Nat Med"},{"issue":"12","key":"48_CR004818","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/70928","volume":"5","author":"N Ferrara","year":"1999","unstructured":"Ferrara N, Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5(12):1359\u20131364. doi:10.1038\/70928","journal-title":"Nat Med"},{"volume-title":"Therapeutic angiogenesis for vascular diseases molecular mechanisms and targeted clinical approaches for the treatment of angiogenic disease","year":"2011","key":"48_CR004819","unstructured":"Slevin M (ed) (2011) Therapeutic angiogenesis for vascular diseases molecular mechanisms and targeted clinical approaches for the treatment of angiogenic disease. Springer, London"},{"issue":"4","key":"48_CR004820","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrd2115","volume":"6","author":"J Folkman","year":"2007","unstructured":"Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6(4):273\u2013286. doi:nrd2115 [pii] or 10.1038\/nrd2115","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"48_CR004821","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2174\/156800905774932806","volume":"5","author":"D Ribatti","year":"2005","unstructured":"Ribatti D, Vacca A (2005) Novel therapeutic approaches targeting vascular endothelial growth factor and its receptors in haematological malignancies. Curr Cancer Drug Targets 5(8):573\u2013578","journal-title":"Curr Cancer Drug Targets"},{"issue":"6","key":"48_CR004822","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10585-010-9312-5","volume":"27","author":"A Albini","year":"2010","unstructured":"Albini A, Indraccolo S, Noonan DM, Pfeffer U (2010) Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs. Clin Exp Metastasis 27(6):419\u2013439. doi:10.1007\/s10585-010-9312-5","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"48_CR004823","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0093-7754(01)90021-1","volume":"28","author":"J Folkman","year":"2001","unstructured":"Folkman J (2001) Angiogenesis-dependent diseases. Semin Oncol 28(6):536\u2013542. doi:S0093775401002640 [pii]","journal-title":"Semin Oncol"},{"issue":"5","key":"48_CR004824","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0306-3623(01)00111-2","volume":"35","author":"ME Maragoudakis","year":"2000","unstructured":"Maragoudakis ME (2000) Angiogenesis in health and disease. Gen Pharmacol 35(5):225\u2013226. doi:S0306362301001112 [pii]","journal-title":"Gen Pharmacol"},{"issue":"8","key":"48_CR004825","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1001\/jama.292.8.972","volume":"292","author":"B Sivakumar","year":"2004","unstructured":"Sivakumar B, Harry LE, Paleolog EM (2004) Modulating angiogenesis: more vs less. JAMA 292(8):972\u2013977. doi:10.1001\/jama.292.8.972 or 292\/8\/972 [pii]","journal-title":"JAMA"},{"key":"48_CR004826","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-6882-9-15","volume":"9","author":"FC Lopes","year":"2009","unstructured":"Lopes FC, Rocha A, Pirraco A, Regasini LO, Silva DH, Bolzani VS, Azevedo I, Carlos IZ, Soares R (2009) Anti-angiogenic effects of pterogynidine alkaloid isolated from Alchornea glandulosa. BMC Complement Altern Med 9:15. doi:1472-6882-9-15 [pii] or 10.1186\/1472-6882-9-15","journal-title":"BMC Complement Altern Med"},{"issue":"3\u20134","key":"48_CR004827","first-page":"199","volume":"29","author":"GC Bernas","year":"2003","unstructured":"Bernas GC (2003) Angiotherapeutics from natural products: from bench to clinics? Clin Hemorheol Microcirc 29(3\u20134):199\u2013203","journal-title":"Clin Hemorheol Microcirc"},{"issue":"9","key":"48_CR004828","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1055\/s-0029-1240813","volume":"76","author":"KW Ng","year":"2010","unstructured":"Ng KW, Salhimi SM, Majid AM, Chan KL (2010) Anti-angiogenic and cytotoxicity studies of some medicinal plants. Planta Med 76(9):935\u2013940. doi:10.1055\/s-0029-1240813","journal-title":"Planta Med"},{"issue":"6","key":"48_CR004829","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.tips.2006.04.006","volume":"27","author":"TP Fan","year":"2006","unstructured":"Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN (2006) Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci 27(6):297\u2013309. doi:S0165-6147(06)00109-X [pii] or 10.1016\/j.tips.2006.04.006","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"48_CR004830","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/138955705774575291","volume":"5","author":"KA El Sayed","year":"2005","unstructured":"El Sayed KA (2005) Natural products as angiogenesis modulators. Mini Rev Med Chem 5(11):971\u2013993","journal-title":"Mini Rev Med Chem"},{"issue":"1\u20132","key":"48_CR004831","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1021528628524","volume":"5","author":"JL Whatmore","year":"2002","unstructured":"Whatmore JL, Swann E, Barraja P, Newsome JJ, Bunderson M, Beall HD, Tooke JE, Moody CJ (2002) Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents. Angiogenesis 5(1\u20132):45\u201351","journal-title":"Angiogenesis"},{"issue":"7\/8","key":"48_CR004832","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1365\/s10337-008-0767-3","volume":"68","author":"M Wu","year":"2008","unstructured":"Wu M, Ma C, Wu Y, Li S (2008) Simultaneous LC analysis of five bioactive alkaloids in an anti-angiogenic herbal formula, Qing-Luo-Yin. Chromatographia 68(7\/8):579\u2013585","journal-title":"Chromatographia"},{"issue":"8\u20139","key":"48_CR004833","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1351\/pac199567081307","volume":"67","author":"GP Moss","year":"1995","unstructured":"Moss GP, Smith PAS, Tavernier D (1995) Glossary of class names of organic-compounds and reactive intermediates based on structure. Pure Appl Chem 67(8\u20139):1307\u20131375. doi:10.1351\/pac199567081307","journal-title":"Pure Appl Chem"},{"issue":"2","key":"48_CR004834","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.phytochem.2006.10.004","volume":"68","author":"L Grycova","year":"2007","unstructured":"Grycova L, Dostal J, Marek R (2007) Quaternary protoberberine alkaloids. Phytochemistry 68(2):150\u2013175. doi:S0031-9422(06)00626-1 [pii] or 10.1016\/j.phytochem.2006.10.004","journal-title":"Phytochemistry"},{"issue":"1","key":"48_CR004835","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jep.2009.08.009","volume":"126","author":"J Tang","year":"2009","unstructured":"Tang J, Feng Y, Tsao S, Wang N, Curtain R, Wang Y (2009) Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 126(1):5\u201317. doi:S0378-8741(09)00490-5 [pii] or 10.1016\/j.jep. 2009.08.009","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"48_CR004836","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1440-1746.2010.06389.x","volume":"26","author":"S Jie","year":"2011","unstructured":"Jie S, Li H, Tian Y, Guo D, Zhu J, Gao S, Jiang L (2011) Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J Gastroenterol Hepatol 26(1):179\u2013185. doi:10.1111\/j.1440-1746.2010.06389.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"48_CR004837","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1124\/mol.66.3. or 66\/3\/612 [pii]","volume":"66","author":"S Lin","year":"2004","unstructured":"Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG (2004) Berberine inhibits HIF-1a expression via enhanced proteolysis. Mol Pharmacol 66(3):612\u2013619. doi:10.1124\/mol.66.3. or 66\/3\/612 [pii]","journal-title":"Mol Pharmacol"},{"issue":"8","key":"48_CR004838","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/S0031-9422(00)97924-X","volume":"28","author":"RD Williams","year":"1989","unstructured":"Williams RD, Ellis BE (1989) Age and tissue distribution of alkaloids in Papaver-somniferum. Phytochemistry 28(8):2085\u20132088. doi:10.1016\/s0031-9422(00)97924-x","journal-title":"Phytochemistry"},{"issue":"3","key":"48_CR004839","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1378\/chest.32.3.305","volume":"32","author":"MS Segal","year":"1957","unstructured":"Segal MS, Goldstein MM, Attinger EO (1957) The use of noscapine (narcotine) as an antitussive agent. Dis Chest 32(3):305\u2013309","journal-title":"Dis Chest"},{"key":"48_CR004840","first-page":"81","volume":"10","author":"M Mahmoudian","year":"2006","unstructured":"Mahmoudian M (2006) Recent progress in clinical application of noscapine: a review. Curr Topic Pharmacol 10:81\u201386","journal-title":"Curr Topic Pharmacol"},{"issue":"5","key":"48_CR004841","first-page":"1121","volume":"28","author":"EW Newcomb","year":"2006","unstructured":"Newcomb EW, Lukyanov Y, Schnee T, Ali MA, Lan L, Zagzag D (2006) Noscapine inhibits hypoxia-mediated HIF-1a expression and angiogenesis in vitro: a novel function for an old drug. Int J Oncol 28(5):1121\u20131130","journal-title":"Int J Oncol"},{"issue":"10","key":"48_CR004842","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3(10):721\u2013732. doi:10.1038\/nrc1187 or nrc1187 [pii]","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"48_CR004843","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrd1199","volume":"2","author":"A Giaccia","year":"2003","unstructured":"Giaccia A, Siim BG, Johnson RS (2003) HIF-1 as a target for drug development. Nat Rev Drug Discov 2(10):803\u2013811. doi:10.1038\/nrd1199 or nrd1199 [pii]","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"48_CR004844","first-page":"7","volume":"56","author":"RJ Harkrader","year":"1990","unstructured":"Harkrader RJ, Reinhart PC, Rogers JA, Jones RR, Wylie RE 2nd, Lowe BK, McEvoy RM (1990) The history, chemistry and pharmacokinetics of Sanguinaria extract. J Can Dent Assoc 56(7 Suppl):7\u201312","journal-title":"J Can Dent Assoc"},{"issue":"3","key":"48_CR004845","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0889-5406(89)90456-3","volume":"96","author":"JJ Hannah","year":"1989","unstructured":"Hannah JJ, Johnson JD, Kuftinec MM (1989) Long-term clinical evaluation of toothpaste and oral rinse containing sanguinaria extract in controlling plaque, gingival inflammation, and sulcular bleeding during orthodontic treatment. Am J Orthod Dentofacial Orthop 96(3):199\u2013207. doi:0889-5406(89)90456-3 [pii]","journal-title":"Am J Orthod Dentofacial Orthop"},{"issue":"4","key":"48_CR004846","first-page":"1524","volume":"6","author":"N Ahmad","year":"2000","unstructured":"Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000) Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 6(4):1524\u20131528","journal-title":"Clin Cancer Res"},{"issue":"11","key":"48_CR004847","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.bcp.2009.07.011","volume":"78","author":"I De Stefano","year":"2009","unstructured":"De Stefano I, Raspaglio G, Zannoni GF, Travaglia D, Prisco MG, Mosca M, Ferlini C, Scambia G, Gallo D (2009) Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem Pharmacol 78(11):1374\u20131381. doi:S0006-2952(09)00643-1 [pii] or 10.1016\/j.bcp. 2009.07.011","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"48_CR004848","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.bbrc.2004.03.077","volume":"317","author":"JP Eun","year":"2004","unstructured":"Eun JP, Koh GY (2004) Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem Biophys Res Commun 317(2):618\u2013624. doi:10.1016\/j.bbrc.2004.03.077 or S0006291X04005534 [pii]","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"48_CR004849","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/biof.5520290102","volume":"29","author":"G Basini","year":"2007","unstructured":"Basini G, Bussolati S, Santini SE, Grasselli F (2007) Sanguinarine inhibits VEGF-induced angiogenesis in a fibrin gel matrix. Biofactors 29(1):11\u201318","journal-title":"Biofactors"},{"issue":"3","key":"48_CR004850","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.reprotox.2005.10.001","volume":"21","author":"F Bianco","year":"2006","unstructured":"Bianco F, Basini G, Grasselli F (2006) The plant alkaloid Sanguinarine affects swine granulosa cell activity. Reprod Toxicol 21(3):335\u2013340. doi:S0890-6238(05)00222-4 [pii] or 10.1016\/j.reprotox.2005.10.001","journal-title":"Reprod Toxicol"},{"issue":"1","key":"48_CR004851","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0031-9422(00)86628-5","volume":"9","author":"CW Thornber","year":"1970","unstructured":"Thornber CW (1970) Alkaloids of the Menispermaceae. Phytochemistry 9(1):157\u2013187","journal-title":"Phytochemistry"},{"issue":"10","key":"48_CR004852","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0192-0561(96)00025-2","volume":"18","author":"L Liu","year":"1996","unstructured":"Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, Kinne RW (1996) Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. Int J Immunopharmacol 18(10):529\u2013543. doi:S0192056196000252 [pii]","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"48_CR004853","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10456-005-2892-z","volume":"8","author":"TW Kok","year":"2005","unstructured":"Kok TW, Yue PY, Mak NK, Fan TP, Liu L, Wong RN (2005) The anti-angiogenic effect of sinomenine. Angiogenesis 8(1):3\u201312. doi:10.1007\/s10456-005-2892-z","journal-title":"Angiogenesis"},{"issue":"7","key":"48_CR004854","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.lfs.2006.02.014","volume":"79","author":"XJ Li","year":"2006","unstructured":"Li XJ, Yue PY, Ha WY, Wong DY, Tin MM, Wang PX, Wong RN, Liu L (2006) Effect of sinomenine on gene expression of the IL-1b-activated human synovial sarcoma. Life Sci 79(7):665\u2013673. doi:S0024-3205(06)00157-3 [pii] or 10.1016\/j.lfs.2006.02.014","journal-title":"Life Sci"},{"issue":"1","key":"48_CR004855","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1590\/S0103-50532007000100002","volume":"18","author":"A Salatino","year":"2007","unstructured":"Salatino A, Salatino MLF, Negri G (2007) Traditional uses, chemistry and pharmacology of Croton species (Euphorbiaceae). J Braz Chem Soc 18(1):11\u201333. doi:10.1590\/s0103-50532007000100002","journal-title":"J Braz Chem Soc"},{"issue":"2","key":"48_CR004856","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1055\/s-2006-961907","volume":"55","author":"AJ Vaisberg","year":"1989","unstructured":"Vaisberg AJ, Milla M, Planas MC, Cordova JL, de Agusti ER, Ferreyra R, Mustiga MC, Carlin L, Hammond GB (1989) Taspine is the cicatrizant principle in Sangre de Grado extracted from Croton lechleri. Planta Med 55(2):140\u2013143. doi:10.1055\/s-2006-961907","journal-title":"Planta Med"},{"issue":"9","key":"48_CR004857","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1021\/np060268p","volume":"69","author":"JM Rollinger","year":"2006","unstructured":"Rollinger JM, Schuster D, Baier E, Ellmerer EP, Langer T, Stuppner H (2006) Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana. J Nat Prod 69(9):1341\u20131346. doi:10.1021\/np060268p","journal-title":"J Nat Prod"},{"issue":"1\u20132","key":"48_CR004858","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.phymed.2007.09.021","volume":"15","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, He L, Zhou Y (2008) Taspine isolated from Radix et Rhizoma Leonticis inhibits growth of human umbilical vein endothelial cell (HUVEC) by inducing its apoptosis. Phytomedicine 15(1\u20132):112\u2013119. doi:S0944-7113(07)00231-0 [pii] or 10.1016\/j.phymed.2007.09.021","journal-title":"Phytomedicine"},{"issue":"5","key":"48_CR004859","first-page":"2183","volume":"61","author":"JE Nor","year":"2001","unstructured":"Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ (2001) Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61(5):2183\u20132188","journal-title":"Cancer Res"},{"issue":"3","key":"48_CR004860","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ptr.3268","volume":"25","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Jiang Q, Wang N, Dai B, Chen Y, He L (2011) Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax\/Bcl-2 in A431 cells. Phytother Res 25(3):357\u2013364. doi:10.1002\/ptr.3268","journal-title":"Phytother Res"},{"issue":"2","key":"48_CR004861","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.bmcl.2009.11.073","volume":"20","author":"J Zhang","year":"2010","unstructured":"Zhang J, Zhang Y, Zhang S, Wang S, He L (2010) Discovery of novel taspine derivatives as antiangiogenic agents. Bioorg Med Chem Lett 20(2):718\u2013721. doi:S0960-894X(09)01643-6 [pii] or 10.1016\/j.bmcl.2009.11.073","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"48_CR004862","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.etap.2011.02.001","volume":"31","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Zhang J, Dai B, Wang N, He L (2011) Anti-proliferative and apoptotic effects of the novel taspine derivative tas41 in the Caco-2 cell line. Environ Toxicol Pharmacol 31(3):406\u2013415. doi:S1382-6689(11)00013-5 [pii] or 10.1016\/j.etap. 2011.02.001","journal-title":"Environ Toxicol Pharmacol"},{"issue":"7","key":"48_CR004863","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.ejmech.2010.03.001","volume":"45","author":"J Zhang","year":"2010","unstructured":"Zhang J, Zhang Y, Shan Y, Li N, Ma W, He L (2010) Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents. Eur J Med Chem 45(7):2798\u20132805. doi:S0223-5234(10)00195-9 [pii] or 10.1016\/j.ejmech.2010.03.001","journal-title":"Eur J Med Chem"},{"issue":"4","key":"48_CR004864","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/157340611796150914","volume":"7","author":"J Zhang","year":"2011","unstructured":"Zhang J, Zhang Y, Pan X, Wang S, He L (2011) Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents. Med Chem 7(4):286\u2013294. doi:BSP\/MC\/Epub\/092 [pii]","journal-title":"Med Chem"},{"issue":"11","key":"48_CR004865","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0031-9422(00)91024-0","volume":"19","author":"DS Bhakuni","year":"1980","unstructured":"Bhakuni DS, Jain S, Singh AN (1980) Biosynthesis of the benzylisoquinoline alkaloid, tetrandrine. Phytochemistry 19(11):2347\u20132350","journal-title":"Phytochemistry"},{"issue":"9","key":"48_CR004866","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1021\/np9700174","volume":"60","author":"PL Schiff","year":"1997","unstructured":"Schiff PL (1997) Bisbenzylisoquinoline alkaloids. J Nat Prod 60(9):934\u2013953. doi:10.1021\/np9700174","journal-title":"J Nat Prod"},{"issue":"2","key":"48_CR004867","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0378-8741(99)00141-5","volume":"69","author":"HS Choi","year":"2000","unstructured":"Choi HS, Kim HS, Min KR, Kim Y, Lim HK, Chang YK, Chung MW (2000) Anti-inflammatory effects of fangchinoline and tetrandrine. J Ethnopharmacol 69(2):173\u2013179. doi:S0378-8741(99)00141-5 [pii]","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"48_CR004868","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00280-007-0416-9","volume":"60","author":"J Wei","year":"2007","unstructured":"Wei J, Liu B, Wang L, Qian X, Ding Y, Yu L (2007) Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemother Pharmacol 60(5):703\u2013711. doi:10.1007\/s00280-007-0416-9","journal-title":"Cancer Chemother Pharmacol"},{"issue":"11","key":"48_CR004869","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/ptr.2196","volume":"21","author":"J Sun","year":"2007","unstructured":"Sun J, Liu BR, Hu WJ, Yu LX, Qian XP (2007) In vitro anticancer activity of aqueous extracts and ethanol extracts of fifteen traditional Chinese medicines on human digestive tumor cell lines. Phytother Res 21(11):1102\u20131104. doi:10.1002\/ptr.2196","journal-title":"Phytother Res"},{"issue":"10","key":"48_CR004870","first-page":"320","volume":"27","author":"X-P Qian","year":"2008","unstructured":"Qian X-P, Liu B-R, Hu J, Li M, Hu W-J, Sun J, Yu L-X (2008) Inhibitory effect of tetrandrine on angiogenesis. Chin J Cancer 27(10):320\u2013324. doi:1000-467X2008101050 [pii]","journal-title":"Chin J Cancer"},{"issue":"4","key":"48_CR004871","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1248\/bpb.21.346","volume":"21","author":"S Kobayashi","year":"1998","unstructured":"Kobayashi S, Inaba K, Kimura I, Kimura M (1998) Inhibitory effects of tetrandrine on angiogenesis in adjuvant-induced chronic inflammation and tube formation of vascular endothelial cells. Biol Pharm Bull 21(4):346\u2013349","journal-title":"Biol Pharm Bull"},{"issue":"4","key":"48_CR004872","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1248\/bpb.22.360","volume":"22","author":"S Kobayashi","year":"1999","unstructured":"Kobayashi S, Kimura I, Fukuta M, Kontani H, Inaba K, Niwa M, Mita S, Kimura M (1999) Inhibitory effects of tetrandrine and related synthetic compounds on angiogenesis in streptozotocin-diabetic rodents. Biol Pharm Bull 22(4):360\u2013365","journal-title":"Biol Pharm Bull"},{"issue":"2\u20133","key":"48_CR004873","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0378-8741(83)90032-6","volume":"9","author":"FC Ohiri","year":"1983","unstructured":"Ohiri FC, Verpoorte R, Svendsen AB (1983) The African Strychnos species and their alkaloids \u2013 a review. J Ethnopharmacol 9(2\u20133):167\u2013223. doi:10.1016\/0378-8741(83)90032-6","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"48_CR004874","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.toxicon.2004.05.006","volume":"44","author":"G Philippe","year":"2004","unstructured":"Philippe G, Angenot L, Tits M, Frederich M (2004) About the toxicity of some Strychnos species and their alkaloids. Toxicon 44(4):405\u2013416. doi:10.1016\/j.toxicon.2004.05.006","journal-title":"Toxicon"},{"issue":"23","key":"48_CR004875","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/S0957-4166(02)00715-2","volume":"13","author":"K Zaruba","year":"2002","unstructured":"Zaruba K, Kral V (2002) Quaternized brucine as a novel chiral selector. Tetrahedron-Asymmetry 13(23):2567\u20132570. doi:Pii s0957-4166(02)00715-2 or 10.1016\/s0957-4166(02)00715-2","journal-title":"Tetrahedron-Asymmetry"},{"issue":"5\u20136","key":"48_CR004876","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.lfs.2011.05.020","volume":"89","author":"SS Agrawal","year":"2011","unstructured":"Agrawal SS, Saraswati S, Mathur R, Pandey M (2011) Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line. Life Sci 89(5\u20136):147\u2013158. doi:10.1016\/j.lfs.2011.05.020","journal-title":"Life Sci"},{"issue":"3","key":"48_CR004877","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.bionut.2011.06.014","volume":"1","author":"SS Agrawal","year":"2011","unstructured":"Agrawal SS, Saraswati S, Mathur R, Pandey M (2011) Brucine, a plant derived alkaloid inhibits inflammatory angiogenesis in a murine sponge model. Biomed Prev Nutr 1(3):180\u2013185","journal-title":"Biomed Prev Nutr"},{"issue":"6","key":"48_CR004878","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1055\/s-2000-8615","volume":"66","author":"Y Kobayashi","year":"2000","unstructured":"Kobayashi Y, Nakano Y, Hoshikuma K, Yokoo Y, Kamiya T (2000) The bronchoconstrictive action of evodiamine, an indoloquinazoline alkaloid isolated from the fruits of Evodia rutaecarpa, on guinea-pig isolated bronchus: possible involvement on vanilloid receptors. Planta Med 66(6):526\u2013530. doi:10.1055\/s-2000-8615","journal-title":"Planta Med"},{"issue":"1","key":"48_CR004879","first-page":"30","volume":"80","author":"JF Liao","year":"1981","unstructured":"Liao JF, Chen CF, Chow SY (1981) Pharmacological studies of Chinese herbs. Pharmacological effects of Evodiae fructus (author\u2019s transl). J Formos Med Assoc 80(1):30\u201338","journal-title":"J Formos Med Assoc"},{"issue":"16","key":"48_CR004880","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1039\/b404506h","volume":"2","author":"LV Pearce","year":"2004","unstructured":"Pearce LV, Petukhov PA, Szabo T, Kedei N, Bizik F, Kozikowski AP, Blumberg PM (2004) Evodiamine functions as an agonist for the vanilloid receptor TRPV1. Org Biomol Chem 2(16):2281\u20132286. doi:10.1039\/B404506H","journal-title":"Org Biomol Chem"},{"issue":"7","key":"48_CR004881","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1055\/s-2001-17353","volume":"67","author":"Y Kobayashi","year":"2001","unstructured":"Kobayashi Y, Nakano Y, Kizaki M, Hoshikuma K, Yokoo Y, Kamiya T (2001) Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med 67(7):628\u2013633. doi:10.1055\/s-2001-17353","journal-title":"Planta Med"},{"issue":"5","key":"48_CR004882","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/molecules14051852","volume":"14","author":"J Jiang","year":"2009","unstructured":"Jiang J, Hu C (2009) Evodiamine: a novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 14(5):1852\u20131859. doi:14051852 [pii] or 10.3390\/molecules14051852","journal-title":"Molecules"},{"issue":"19","key":"48_CR004883","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.lfs.2005.09.027","volume":"78","author":"KG Shyu","year":"2006","unstructured":"Shyu KG, Lin S, Lee CC, Chen E, Lin LC, Wang BW, Tsai SC (2006) Evodiamine inhibits in vitro angiogenesis: implication for antitumorgenicity. Life Sci 78(19):2234\u20132243. doi:S0024-3205(05)01060-X [pii] or 10.1016\/j.lfs.2005.09.027","journal-title":"Life Sci"},{"issue":"8","key":"48_CR004884","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/S0031-9422(00)83773-5","volume":"19","author":"JRF Allen","year":"1980","unstructured":"Allen JRF, Holmstedt BR (1980) The simple \u03b2-carboline alkaloids. Phytochemistry 19(8):1573\u20131582. doi:10.1016\/s0031-9422(00)83773-5","journal-title":"Phytochemistry"},{"issue":"2","key":"48_CR004885","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00005053-199602000-00004","volume":"184","author":"CS Grob","year":"1996","unstructured":"Grob CS, McKenna DJ, Callaway JC, Brito GS, Neves ES, Oberlaender G, Saide OL, Labigalini E, Tacla C, Miranda CT, Strassman RJ, Boone KB (1996) Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. J Nerv Ment Dis 184(2):86\u201394","journal-title":"J Nerv Ment Dis"},{"issue":"23","key":"48_CR004886","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1016\/S0960-894X(99)00598-3","volume":"9","author":"J Ishida","year":"1999","unstructured":"Ishida J, Wang HK, Bastow KF, Hu CQ, Lee KH (1999) Antitumor agents 201. Cytotoxicity of harmine and b-carboline analogs. Bioorg Med Chem Lett 9(23):3319\u20133324. doi:S0960894X99005983 [pii]","journal-title":"Bioorg Med Chem Lett"},{"issue":"1\u20133","key":"48_CR004887","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2010.09.010","volume":"649","author":"TP Hamsa","year":"2010","unstructured":"Hamsa TP, Kuttan G (2010) Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Eur J Pharmacol 649(1\u20133):64\u201373. doi:S0014-2999(10)00890-3 [pii] or 10.1016\/j.ejphar.2010.09.010","journal-title":"Eur J Pharmacol"},{"key":"48_CR004888","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0040-4039(01)97839-6","volume":"11","author":"RG Powell","year":"1970","unstructured":"Powell RG, Weisleder D, Smith CR Jr, Rohwedder WK (1970) Structures of harringtonine, isoharringtonine, and homoharringtonine. Tetrahedron Lett 11:815\u2013818","journal-title":"Tetrahedron Lett"},{"volume-title":"Anticancer agents based on natural products models, medicinal chemistry","year":"1980","key":"48_CR004889","unstructured":"Cassady JM, Douros JD (eds) (1980) Anticancer agents based on natural products models, medicinal chemistry. Academic, New York"},{"issue":"6","key":"48_CR004890","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U","volume":"92","author":"HM Kantarjian","year":"2001","unstructured":"Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O'Brien SM (2001) Homoharringtonine: history, current research, and future direction. Cancer 92(6):1591\u20131605. doi:10.1002\/1097-0142(20010915)92:6<1591::AID-CNCR1485>3.0.CO;2-U [pii]","journal-title":"Cancer"},{"key":"48_CR004891","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1631\/jzus.2004.0230","volume":"5","author":"XJ Ye","year":"2004","unstructured":"Ye XJ, Lin MF (2004) Homoharringtonine induces apoptosis of endothelium and dowregulates VEGF expression of K562 cells. J Zhejiang Univ Sci A 5:230\u2013234","journal-title":"J Zhejiang Univ Sci A"},{"issue":"1","key":"48_CR004892","first-page":"27","volume":"26","author":"J Fei","year":"2005","unstructured":"Fei J, Zhang H (2005) Vascular endothelial growth factor antisense oligodeoxynucleotide enhance drug-sensitivity of myeloid leukemia cells to homoharringtonine. Chin J Hematol 26(1):27\u201330","journal-title":"Chin J Hematol"},{"issue":"2","key":"48_CR004893","first-page":"9","volume":"18","author":"Jp Liu","year":"2003","unstructured":"Liu Jp, Xie Cm, Jia K, Yang Zs (2003) Inhibition of angiogenesis on CAM by homoharringtonine. J North Sichuan Med College 18(2):9\u201311, 2003","journal-title":"J North Sichuan Med College"},{"issue":"7","key":"48_CR004894","first-page":"47","volume":"27","author":"B-Z Li","year":"2008","unstructured":"Li B-Z, Zhuang W-Z, Chen P, Fu J-X (2008) Effects of RNA interference targeting hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) on chemosensitivity of leukemia K562 cells towards homoharringtonine. Chin J Cancer 27(7):47\u201352","journal-title":"Chin J Cancer"},{"key":"48_CR004895","volume-title":"Catharanthus Alkaloids","author":"GH Svoboda","year":"1975","unstructured":"Svoboda GH, Blake DA (1975) The phytochemistry and pharmacology of Catharanthus roseus (L.) G. Don. In: Taylor WI, Farnsworth NR (eds) Catharanthus Alkaloids. Marcel Dekker, New York"},{"key":"48_CR004896","volume-title":"Antitumor bisindole alkaloids from Catharanthus roseus (L.)","author":"A Brossi","year":"1990","unstructured":"Brossi A, Suffness M (1990) Antitumor bisindole alkaloids from Catharanthus roseus (L.). Academic, San Diego"},{"key":"48_CR004897","volume-title":"Cancer: principles and practice of oncology","author":"EK Rowinsky","year":"2001","unstructured":"Rowinsky EK, Tolcher AW (2001) Antimicrotubule agents. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 6th edn. Lippincott-Raven, Philadelphia","edition":"6"},{"issue":"12","key":"48_CR004898","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1054\/bjoc.2000.1203","volume":"82","author":"RK Gregory","year":"2000","unstructured":"Gregory RK, Smith IE (2000) Vinorelbine\u2013a clinical review. Br J Cancer 82(12):1907\u20131913. doi:S0007092000912035 [pii] or 10.1054\/bjoc.2000.1203","journal-title":"Br J Cancer"},{"issue":"13","key":"48_CR004899","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1200\/JCO.2009.23.4146","volume":"28","author":"M Krzakowski","year":"2010","unstructured":"Krzakowski M, Ramlau R, Jassem J, Szczesna A, Zatloukal P, Von Pawel J, Sun X, Bennouna J, Santoro A, Biesma B, Delgado FM, Salhi Y, Vaissiere N, Hansen O, Tan EH, Quoix E, Garrido P, Douillard JY (2010) Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy. J Clin Oncol 28(13):2167\u20132173. doi:JCO.2009.23.4146 [pii] or 10.1200\/JCO.2009.23.4146","journal-title":"J Clin Oncol"},{"issue":"12","key":"48_CR0048100","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1182\/blood.V94.12.4143","volume":"94","author":"A Vacca","year":"1999","unstructured":"Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, Ria R, Pellegrino A, Dammacco F (1999) Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 94(12):4143\u20134155","journal-title":"Blood"},{"issue":"41","key":"48_CR0048101","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1038\/sj.onc.1206789","volume":"22","author":"D Ribatti","year":"2003","unstructured":"Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, Parnigotto PP, Vacca A, Nussdorfer GG (2003) Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene 22(41):6458\u20136461. doi:10.1038\/sj.onc.1206789 or 1206789 [pii]","journal-title":"Oncogene"},{"issue":"45","key":"48_CR0048102","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1038\/sj.onc.1208829","volume":"24","author":"D Marimpietri","year":"2005","unstructured":"Marimpietri D, Nico B, Vacca A, Mangieri D, Catarsi P, Ponzoni M, Ribatti D (2005) Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin. Oncogene 24(45):6785\u20136795. doi:1208829 [pii] or 10.1038\/sj.onc.1208829","journal-title":"Oncogene"},{"issue":"3","key":"48_CR0048103","first-page":"285","volume":"22","author":"D Ribatti","year":"2007","unstructured":"Ribatti D, Nico B, Mangieri D, Longo V, Sansonno D, Vacca A, Dammacco F (2007) In vivo inhibition of human hepatocellular carcinoma related angiogenesis by vinblastine and rapamycin. Histol Histopathol 22(3):285\u2013289","journal-title":"Histol Histopathol"},{"issue":"15","key":"48_CR0048104","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1002\/pmic.200600119","volume":"6","author":"N Campostrini","year":"2006","unstructured":"Campostrini N, Marimpietri D, Totolo A, Mancone C, Fimia GM, Ponzoni M, Righetti PG (2006) Proteomic analysis of anti-angiogenic effects by a combined treatment with vinblastine and rapamycin in an endothelial cell line. Proteomics 6(15):4420\u20134431. doi:10.1002\/pmic.200600119","journal-title":"Proteomics"},{"issue":"2","key":"48_CR0048105","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/02841860701558781","volume":"47","author":"P Albertsson","year":"2008","unstructured":"Albertsson P, Lennernas B, Norrby K (2008) Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A. Acta Oncol 47(2):293\u2013300. doi:785016895 [pii] or 10.1080\/02841860701558781","journal-title":"Acta Oncol"},{"issue":"4A","key":"48_CR0048106","first-page":"2281","volume":"21","author":"IA Avramis","year":"2001","unstructured":"Avramis IA, Kwock R, Avramis VI (2001) Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines. Anticancer Res 21(4A):2281\u20132286","journal-title":"Anticancer Res"},{"issue":"16","key":"48_CR0048107","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1016\/j.ejca.2006.06.019","volume":"42","author":"A Kruczynski","year":"2006","unstructured":"Kruczynski A, Poli M, Dossi R, Chazottes E, Berrichon G, Ricome C, Giavazzi R, Hill BT, Taraboletti G (2006) Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development. Eur J Cancer 42(16):2821\u20132832. doi:S0959-8049(06)00602-2 [pii] or 10.1016\/j.ejca.2006.06.019","journal-title":"Eur J Cancer"},{"issue":"7","key":"48_CR0048108","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1158\/1535-7163.MCT-08-0156","volume":"7","author":"S Honore","year":"2008","unstructured":"Honore S, Pagano A, Gauthier G, Bourgarel-Rey V, Verdier-Pinard P, Civiletti K, Kruczynski A, Braguer D (2008) Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites. Mol Cancer Ther 7(7):2080\u20132089. doi:7\/7\/2080 [pii] or 10.1158\/1535-7163.MCT-08-0156","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"48_CR0048109","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1021\/np50019a005","volume":"45","author":"E Gellert","year":"1982","unstructured":"Gellert E (1982) The indolizidine alkaloids. J Nat Prod 45(1):50\u201373. doi:10.1021\/np50019a005","journal-title":"J Nat Prod"},{"key":"48_CR0048110","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1055\/s-2001-18703","volume":"16","author":"ZG Li","year":"2001","unstructured":"Li ZG, Jin Z, Huang RQ (2001) Isolation, total synthesis and biological activity of phenanthroindolizidine and phenanthroquinolizidine alkaloids. Synthesis-Stuttgart 16:2365\u20132378","journal-title":"Synthesis-Stuttgart"},{"issue":"1","key":"48_CR0048111","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/157340709787580928","volume":"5","author":"SR Chemler","year":"2009","unstructured":"Chemler SR (2009) Phenanthroindolizidines and phenanthroquinolizidines: promising alkaloids for anti-cancer Therapy. Curr Bioact Compd 5(1):2\u201319. doi:10.2174\/157340709787580928","journal-title":"Curr Bioact Compd"},{"issue":"7","key":"48_CR0048112","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/np060081y","volume":"69","author":"XF Cai","year":"2006","unstructured":"Cai XF, Jin X, Lee D, Yang YT, Lee K, Hong YS, Lee JH, Lee JJ (2006) Phenanthroquinolizidine alkaloids from the roots of Boehmeria pannosa potently inhibit hypoxia-inducible factor-1 in AGS human gastric cancer cells. J Nat Prod 69(7):1095\u20131097. doi:10.1021\/np060081y","journal-title":"J Nat Prod"},{"issue":"1","key":"48_CR0048113","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bmcl.2005.09.032","volume":"16","author":"MG Banwell","year":"2006","unstructured":"Banwell MG, Bezos A, Burns C, Kruszelnicki I, Parish CR, Su S, Sydnes MO (2006) C8c-C15 monoseco-analogues of the phenanthroquinolizidine alkaloids julandine and cryptopleurine exhibiting potent anti-angiogenic properties. Bioorg Med Chem Lett 16(1):181\u2013185. doi:S0960-894X(05)01168-6 [pii] or 10.1016\/j.bmcl.2005.09.032","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"48_CR0048114","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1071\/CH08190","volume":"61","author":"MO Sydnes","year":"2008","unstructured":"Sydnes MO, Bezos A, Burns C, Kruszelnicki I, Parish CR, Su S, Rae AD, Willis AC, Banwell MG (2008) Synthesis and biological evaluation of some enantiomerically pure C8c-C15 monoseco analogues of the phenanthroquinolizidine-type alkaloids cryptopleurine and julandine. Aust J Chem 61(7):506\u2013520. doi:10.1071\/ch08190","journal-title":"Aust J Chem"},{"issue":"1","key":"48_CR0048115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0031-9422(75)85038-2","volume":"14","author":"M Izaddoost","year":"1975","unstructured":"Izaddoost M (1975) Alkaloid chemotaxonomy of the genus Sophora. Phytochemistry 14(1):203\u2013204","journal-title":"Phytochemistry"},{"issue":"10","key":"48_CR0048116","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1248\/yakushi1947.120.10_1025","volume":"120","author":"M Yamazaki","year":"2000","unstructured":"Yamazaki M (2000) The pharmacological studies on matrine and oxymatrine. Yakugaku Zasshi 120(10):1025\u20131033","journal-title":"Yakugaku Zasshi"},{"issue":"1","key":"48_CR0048117","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jep.2009.02.022","volume":"123","author":"ZJ Dai","year":"2009","unstructured":"Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT (2009) Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas\/FasL and activation of caspase-3. J Ethnopharmacol 123(1):91\u201396. doi:S0378-8741(09)00114-7 [pii] or 10.1016\/j.jep. 2009.02.022","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"48_CR0048118","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10616-009-9225-9","volume":"59","author":"P Yu","year":"2009","unstructured":"Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G (2009) Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kB signaling. Cytotechnology 59(3):219\u2013229. doi:10.1007\/s10616-009-9225-9","journal-title":"Cytotechnology"},{"issue":"4","key":"48_CR0048119","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11033-008-9247-y","volume":"36","author":"S Zhang","year":"2009","unstructured":"Zhang S, Qi J, Sun L, Cheng B, Pan S, Zhou M, Sun X (2009) Matrine induces programmed cell death and regulates expression of relevant genes based on PCR array analysis in C6 glioma cells. Mol Biol Rep 36(4):791\u2013799. doi:10.1007\/s11033-008-9247-y","journal-title":"Mol Biol Rep"},{"issue":"3","key":"48_CR0048120","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10616-009-9211-2","volume":"59","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Zhang H, Yu P, Liu Q, Liu K, Duan H, Luan G, Yagasaki K, Zhang G (2009) Effects of matrine against the growth of human lung cancer and hepatoma cells as well as lung cancer cell migration. Cytotechnology 59(3):191\u2013200. doi:10.1007\/s10616-009-9211-2","journal-title":"Cytotechnology"},{"issue":"6","key":"48_CR0048121","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1142\/S0192415X10008512","volume":"38","author":"H Li","year":"2010","unstructured":"Li H, Tan G, Jiang X, Qiao H, Pan S, Jiang H, Kanwar JR, Sun X (2010) Therapeutic effects of matrine on primary and metastatic breast cancer. Am J Chin Med 38(6):1115\u20131130. doi:S0192415X10008512 [pii]","journal-title":"Am J Chin Med"},{"key":"48_CR0048122","volume-title":"The alkaloids","author":"T Suzuki","year":"1994","unstructured":"Suzuki T, Iwai K (1994) Constitution of red pepper species: chemistry, biochemistry, pharmacology, and food science of the pungent principle of Capsicum species. In: Brosi A (ed) The alkaloids. Academic, New York"},{"issue":"11","key":"48_CR0048123","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1021\/jm030560j","volume":"47","author":"A Szallasi","year":"2004","unstructured":"Szallasi A, Appendino G (2004) Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? J Med Chem 47(11):2717\u20132723. doi:10.1021\/jm030560j","journal-title":"J Med Chem"},{"issue":"2","key":"48_CR0048124","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1158\/0008-5472.CAN-03-3250","volume":"64","author":"JK Min","year":"2004","unstructured":"Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH, Kim KW, Gho YS, Kwon YG (2004) Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res 64(2):644\u2013651","journal-title":"Cancer Res"},{"issue":"15","key":"48_CR0048125","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0024-3205(00)00459-8","volume":"66","author":"L Ma","year":"2000","unstructured":"Ma L, Chow JY, Wong BC, Cho CH (2000) Role of capsaicin sensory nerves and EGF in the healing of gastric ulcer in rats. Life Sci 66(15):213\u2013220. doi:S0024320500004598 [pii]","journal-title":"Life Sci"},{"issue":"1","key":"48_CR0048126","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/0008-5472.CAN-07-2799","volume":"68","author":"BJ Pyun","year":"2008","unstructured":"Pyun BJ, Choi S, Lee Y, Kim TW, Min JK, Kim Y, Kim BD, Kim JH, Kim TY, Kim YM, Kwon YG (2008) Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity. Cancer Res 68(1):227\u2013235. doi:68\/1\/227 [pii] or 10.1158\/0008-5472.CAN-07-2799","journal-title":"Cancer Res"},{"issue":"3","key":"48_CR0048127","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1128\/AAC.49.3.1169-1176.2005","volume":"49","author":"S Jiang","year":"2005","unstructured":"Jiang S, Zeng Q, Gettayacamin M, Tungtaeng A, Wannaying S, Lim A, Hansukjariya P, Okunji CO, Zhu S, Fang D (2005) Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrob Agents Chemother 49(3):1169\u20131176. doi:49\/3\/1169 [pii] or 10.1128\/AAC.49.3.1169-1176.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"48_CR0048128","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1021\/ja01163a555","volume":"72","author":"JB Koepfli","year":"1950","unstructured":"Koepfli JB, Brockman JA, Moffat J (1950) The structure of febrifugine and isofebrifugine. J Am Chem Soc 72(7):3323\u20133323. doi:10.1021\/ja01163a555","journal-title":"J Am Chem Soc"},{"issue":"7","key":"48_CR0048129","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/ja01199a513","volume":"69","author":"JB Koepfli","year":"1947","unstructured":"Koepfli JB, Mead JF, Brockman JA Jr (1947) An alkaloid with high antimalarial activity from Dichroa febrifuga. J Am Chem Soc 69(7):1837","journal-title":"J Am Chem Soc"},{"issue":"7","key":"48_CR0048130","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","volume":"9","author":"M Pines","year":"2003","unstructured":"Pines M, Snyder D, Yarkoni S, Nagler A (2003) Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant 9(7):417\u2013425. doi:S1083879103001514 [pii]","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3\u20134","key":"48_CR0048131","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/1098-2299(200007\/08)50:3\/4<371::AID-DDR19>3.0.CO;2-R","volume":"50","author":"M Pines","year":"2000","unstructured":"Pines M, Vlodavsky I, Nagler A (2000) Halofuginone: from veterinary use to human therapy. Drug Dev Res 50(3\u20134):371\u2013378. doi:10.1002\/1098-2299(200007\/08)50:3\/4<371::aid-ddr19>3.0.co;2-r","journal-title":"Drug Dev Res"},{"issue":"2","key":"48_CR0048132","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0304-4165(93)90123-P","volume":"1156","author":"I Granot","year":"1993","unstructured":"Granot I, Halevy O, Hurwitz S, Pines M (1993) Halofuginone: an inhibitor of collagen type I synthesis. Biochim Biophys Acta 1156(2):107\u2013112. doi:0304-4165(93)90123-P [pii]","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"48_CR0048133","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1096\/fj.00-0292com","volume":"14","author":"M Elkin","year":"2000","unstructured":"Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, Dou HL, Pines M, Vlodavsky I (2000) Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J 14(15):2477\u20132485. doi:10.1096\/fj.00-0292com or 14\/15\/2477 [pii]","journal-title":"FASEB J"},{"issue":"8","key":"48_CR0048134","first-page":"1982","volume":"5","author":"M Elkin","year":"1999","unstructured":"Elkin M, Reich R, Nagler A, Aingorn E, Pines M, de-Groot N, Hochberg A, Vlodavsky I (1999) Inhibition of matrix metalloproteinase-2 expression and bladder carcinoma metastasis by halofuginone. Clin Cancer Res 5(8):1982\u20131988","journal-title":"Clin Cancer Res"},{"issue":"1","key":"48_CR0048135","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1161\/01.ATV.17.1.194","volume":"17","author":"A Nagler","year":"1997","unstructured":"Nagler A, Miao HQ, Aingorn H, Pines M, Genina O, Vlodavsky I (1997) Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. Arterioscler Thromb Vasc Biol 17(1):194\u2013202","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"48_CR0048136","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1593\/neo.03520","volume":"6","author":"R Abramovitch","year":"2004","unstructured":"Abramovitch R, Itzik A, Harel H, Nagler A, Vlodavsky I, Siegal T (2004) Halofuginone inhibits angiogenesis and growth in implanted metastatic rat brain tumor model\u2013an MRI study. Neoplasia 6(5):480\u2013489. doi:10.1593\/neo.03520","journal-title":"Neoplasia"},{"issue":"2","key":"48_CR0048137","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4161\/cbt.5.2.2419","volume":"5","author":"KO Yee","year":"2006","unstructured":"Yee KO, Connolly CM, Pines M, Lawler J (2006) Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism. Cancer Biol Ther 5(2):218\u2013224. doi:2419 [pii]","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"48_CR0048138","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1039\/c0np00016g","volume":"27","author":"RG Berlinck","year":"2010","unstructured":"Berlinck RG, Burtoloso AC, Trindade-Silva AE, Romminger S, Morais RP, Bandeira K, Mizuno CM (2010) The chemistry and biology of organic guanidine derivatives. Nat Prod Rep 27(12):1871\u20131907. doi:10.1039\/c0np00016g","journal-title":"Nat Prod Rep"},{"issue":"11","key":"48_CR0048139","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1021\/np50125a006","volume":"58","author":"VDS Bolzani","year":"1995","unstructured":"Bolzani VDS, Gunatilaka AAL, Kingston DGI (1995) Bioactive guanidine alkaloids from Pterogyne nitens. J Nat Prod 58(11):1683\u20131688. doi:10.1021\/np50125a006","journal-title":"J Nat Prod"},{"issue":"3","key":"48_CR0048140","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/np800612x","volume":"72","author":"LO Regasini","year":"2009","unstructured":"Regasini LO, Castro-Gamboa I, Silva DH, Furlan M, Barreiro EJ, Ferreira PM, Pessoa C, Lotufo LV, de Moraes MO, Young MC, Bolzani Vda S (2009) Cytotoxic guanidine alkaloids from Pterogyne nitens. J Nat Prod 72(3):473\u2013476. doi:10.1021\/np800612x","journal-title":"J Nat Prod"},{"issue":"5","key":"48_CR0048141","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s13277-010-0064-2","volume":"31","author":"RA Duarte","year":"2010","unstructured":"Duarte RA, Mello ER, Araki C, Bolzani Vda S, Silva DH Siqueira e, Regasini LO, Silva TG, de Morais MC, Ximenes VF, Soares CP (2010) Alkaloids extracted from Pterogyne nitens induce apoptosis in malignant breast cell line. Tumour Biol 31(5):513\u2013522. doi:10.1007\/s13277-010-0064-2","journal-title":"Tumour Biol"}],"container-title":["Natural Products"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-22144-6_48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T15:57:08Z","timestamp":1675785428000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-22144-6_48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9783642221439","9783642221446"],"references-count":141,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-22144-6_48","relation":{},"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"15 May 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}